COMMON STOCK PURCHASE WARRANT CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.Security Agreement • July 31st, 2019 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ___________, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after July 29, 2019 (the “Initial Exercise Date”), and on or prior to the close of business on the five-year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), up to four million eight hundred seven thousand six hundred ninety-five (4,807,695) shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
8% ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE PROMISSORY NOTE DUE JULY 28, 2020Convertible Security Agreement • July 31st, 2019 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • Nevada
THIS 8% ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE PROMISSORY NOTE is one of a series of a duly authorized and validly issued 8% Original Issue Discount Senior Convertible Promissory Note of Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company” or the “Borrower”), having its principal place of business at 3008 W. Lupine, Phoenix, Arizona 85029, designated as its 8% Original Issue Discount Senior Convertible Promissory Note due July 28, 2020 (the “Note”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 31st, 2019 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • Nevada
This Securities Purchase Agreement (this “Agreement”) is dated as of July 29, 2019, among Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
